Transport Cycle of Plasma Membrane Flippase ATP11C by Cryo-EM.


Journal

Cell reports
ISSN: 2211-1247
Titre abrégé: Cell Rep
Pays: United States
ID NLM: 101573691

Informations de publication

Date de publication:
29 09 2020
Historique:
received: 29 05 2020
revised: 29 07 2020
accepted: 09 09 2020
entrez: 30 9 2020
pubmed: 1 10 2020
medline: 16 9 2021
Statut: ppublish

Résumé

ATP11C, a plasma membrane phospholipid flippase, maintains the asymmetric distribution of phosphatidylserine accumulated in the inner leaflet. Caspase-dependent inactivation of ATP11C is essential for an apoptotic "eat me" signal, phosphatidylserine exposure, which prompts phagocytes to engulf cells. We show six cryo-EM structures of ATP11C at 3.0-4.0 Å resolution in five different states of the transport cycle. A structural comparison reveals phosphorylation-driven domain movements coupled with phospholipid binding. Three structures of phospholipid-bound states visualize phospholipid translocation accompanied by the rearrangement of transmembrane helices and an unwound portion at the occlusion site, and thus they detail the basis for head group recognition and the locality of the protein-bound acyl chains in transmembrane grooves. Invariant Lys880 and the surrounding hydrogen-bond network serve as a pivot point for helix bending and precise P domain inclination, which is crucial for dephosphorylation. The structures detail key features of phospholipid translocation by ATP11C, and a common basic mechanism for flippases is emerging.

Identifiants

pubmed: 32997992
pii: S2211-1247(20)31197-9
doi: 10.1016/j.celrep.2020.108208
pii:
doi:

Substances chimiques

Membrane Transport Proteins 0
ATP11C protein, human EC 3.6.1.-
Adenosine Triphosphatases EC 3.6.1.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108208

Informations de copyright

Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests Y.F. is a director of CeSPIA. The other authors declare no competing interests.

Auteurs

Hanayo Nakanishi (H)

Cellular and Structural Physiology Institute, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan.

Tomohiro Nishizawa (T)

Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Katsumori Segawa (K)

WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.

Osamu Nureki (O)

Department of Biological Sciences, Graduate School of Science, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.

Yoshinori Fujiyoshi (Y)

TMDU Advanced Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8501, Japan; CeSPIA, 2-1-1, Otemachi, Chiyoda-ku, Tokyo 100-0004, Japan.

Shigekazu Nagata (S)

WPI Immunology Frontier Research Center, Osaka University, Osaka 565-0871, Japan.

Kazuhiro Abe (K)

Cellular and Structural Physiology Institute, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan; Graduate School of Pharmaceutical Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya 464-8601, Japan. Electronic address: kabe@cespi.nagoya-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH